1198444
1206367
1206379
H3D Vision & Mission
Vision: To be the leading organisation for integrated drug discovery and development on the African continent Mission: Discover and develop innovative, life saving medicines For African patients Through excellence in interdisciplinary,...
H3D Facilities
Facilities H3D has state of the art laboratory equipment and access to modern instrumentation housed in the Department of Chemistry, the Department of Clinical Pharmacology and the Institute of Infectious Disease and Molecular Medicine (IDM) at UCT...
R&D Environment
UCT offers a truly integrated environment for translational research in communicable and non communicable diseases afflicting people in Africa. It has both the infrastructure as well as numerous groups working on pre-clinical and clinical research...
Home > Home

News

Sunday, 8 December 2019
UCT Shares Expertise to Boost Search for New Drugs

Eight innovators from seven African countries have been announced as the inaugural awardees of the Grand Challenges (GC) Africa drug discovery programme. They will be involved in research that will advance the discovery of new drugs to prevent, treat and cure diseases endemic to Africa.

Publication Date:
Fri, 27 Sep 2019 - 14:00
Financial Times: African Scientists Seek Slice of Global Pharmaceutical Industry

A feature on Professor Kelly Chibale and H3D has been published in the  UK-based Financial Times, one of the world's leading news organisations. The article can be found here: https://www.ft.com/content/c3e47c32-c8c2-11e9-af46-b09e8bfe60c0

Publication Date:
Mon, 23 Sep 2019 - 14:00
H3D 2020 Symposium
Celebrating a Decade in Infectious Diseases Drug Discovery in Africa

https://www.h3dsymposium.co.za/

 

Publication Date:
Fri, 15 Mar 2019 - 14:00
Multimillion rand boost for Africa medicines research
University of Cape Town (UCT) alumnus and former chairman and chief executive of Coca-Cola Neville Isdell has donated $1 242 160 (about R18 million) towards research into the discovery of new medicines for infectious diseases at the university’s Drug Discovery and Development Centre (H3D).

The generous donation will be used to establish an initial five-year Neville Isdell Chair in African-centric Drug Discovery and Development at H3D. H3D’s director and founder Professor Kelly Chibale will hold the Chair, which includes the directorship of H3D.

 

Publication Date:
Fri, 15 Mar 2019 - 14:00

Pages